SLXN
Price
$8.30
Change
-$0.56 (-6.32%)
Updated
Aug 6, 04:51 PM (EDT)
Capitalization
5.13M
VRTX
Price
$385.65
Change
+$10.67 (+2.85%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
96.11B
84 days until earnings call
Interact to see
Advertisement

SLXN vs VRTX

Header iconSLXN vs VRTX Comparison
Open Charts SLXN vs VRTXBanner chart's image
Silexion Therapeutics
Price$8.30
Change-$0.56 (-6.32%)
Volume$200
Capitalization5.13M
Vertex Pharmaceuticals
Price$385.65
Change+$10.67 (+2.85%)
Volume$39.73K
Capitalization96.11B
SLXN vs VRTX Comparison Chart in %
Loading...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SLXN vs. VRTX commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLXN is a StrongBuy and VRTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 06, 2025
Stock price -- (SLXN: $8.86 vs. VRTX: $374.98)
Brand notoriety: SLXN and VRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLXN: 38% vs. VRTX: 763%
Market capitalization -- SLXN: $5.13M vs. VRTX: $96.11B
SLXN [@Biotechnology] is valued at $5.13M. VRTX’s [@Biotechnology] market capitalization is $96.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $215.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLXN’s FA Score shows that 1 FA rating(s) are green whileVRTX’s FA Score has 0 green FA rating(s).

  • SLXN’s FA Score: 1 green, 4 red.
  • VRTX’s FA Score: 0 green, 5 red.
According to our system of comparison, SLXN is a better buy in the long-term than VRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLXN’s TA Score shows that 4 TA indicator(s) are bullish while VRTX’s TA Score has 6 bullish TA indicator(s).

  • SLXN’s TA Score: 4 bullish, 5 bearish.
  • VRTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VRTX is a better buy in the short-term than SLXN.

Price Growth

SLXN (@Biotechnology) experienced а -28.61% price change this week, while VRTX (@Biotechnology) price change was -19.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.86%. For the same industry, the average monthly price growth was +14.59%, and the average quarterly price growth was +13.46%.

Reported Earning Dates

VRTX is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (-0.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRTX($96.1B) has a higher market cap than SLXN($5.13M). VRTX YTD gains are higher at: -6.884 vs. SLXN (-70.614). SLXN has higher annual earnings (EBITDA): -16.96M vs. VRTX (-74.9M). SLXN has less debt than VRTX: SLXN (3.48M) vs VRTX (1.65B). VRTX has higher revenues than SLXN: VRTX (11.1B) vs SLXN (0).
SLXNVRTXSLXN / VRTX
Capitalization5.13M96.1B0%
EBITDA-16.96M-74.9M23%
Gain YTD-70.614-6.8841,026%
P/E RatioN/A26.67-
Revenue011.1B-
Total CashN/A6.2B-
Total Debt3.48M1.65B0%
FUNDAMENTALS RATINGS
VRTX: Fundamental Ratings
VRTX
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
60
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SLXNVRTX
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
8%
Bullish Trend 2 days ago
59%
Momentum
ODDS (%)
Bearish Trend 2 days ago
20%
Bearish Trend 2 days ago
48%
MACD
ODDS (%)
Bullish Trend 2 days ago
31%
Bearish Trend 2 days ago
53%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
42%
Bearish Trend 2 days ago
43%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
40%
Advances
ODDS (%)
Bullish Trend 10 days ago
51%
Bullish Trend 3 days ago
60%
Declines
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 13 days ago
42%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
44%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VDE120.240.30
+0.25%
Vanguard Energy ETF
RMIF24.88N/A
+0.02%
LHA Risk-Managed Income ETF
ECF10.50N/A
N/A
Ellsworth Growth and Income Fund Ltd
INDH42.58-0.05
-0.12%
WisdomTree India Hedged Equity
BTCO113.37-1.06
-0.93%
Invesco Galaxy Bitcoin ETF

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
-1.99%
IMA - SLXN
59%
Loosely correlated
-0.66%
CELC - SLXN
50%
Loosely correlated
-0.67%
MRSN - SLXN
43%
Loosely correlated
+2.62%
CHRS - SLXN
26%
Poorly correlated
+4.86%
QSI - SLXN
25%
Poorly correlated
N/A
More